Skip to content

REVAPREVENT

Active
Private limited companyfounded 201015 yrs activeKoning Albert I-laan 25, 8800 Roeselare, BelgiumKBO/BCE: BE 0832.428.660
Summary

REVAPREVENT has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €181,088. Equity is growing by ~8.1% per year across the filed fiscal years. Its solvency ranks better than 94% of 2603 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Overview

What they do
Specialist medical practice
NACE 86220
1 site
How big
€1.6mtotal assets 2025
Equity
€1.5m
Profit
€181,088
Turnover not published (abridged schema)
Financially healthy?
95 Excellent Checked score 2025
Bankruptcy chance 12 m
< 0.1%
Who decides
Accounts 15 d early0 of 5 deeds read
Why 95+ Liquidity: current ratio 28.41, cash €1.2m+ Sector Human health activities (NACE 86)+ Equity €1.5m (96.3% of total assets)+ Size: total assets €1.6mShow the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Better than 60% of its sector peers (NACE 86, micro)
Performance against the sector, not lower risk
Financial strength · tick = 2024
Strong
Solvency 100=
equity 96.3% of total assets
Liquidity 100=
short-term debt 3.5% · cash 78.6%
Profitability 83-12
return on assets 11.5%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (23,628 companies)
  • Liquidity: current ratio 28.41, cash €1.2m lowers the probability
  • Sector Human health activities (NACE 86) lowers the probability
  • Equity €1.5m (96.3% of total assets) lowers the probability
  • Size: total assets €1.6m lowers the probability for this profile
Credit up to €140,000 at 30 days acceptable
Liquidity ample (current ratio 28.41 against 18.53 in 2024; short-term debt: 3.5% and cash: 78.6% of total assets), and 3.7% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, micro). Better than this share of them on solvency 82%, liquidity 95%, profitability 32%, growth against the median 33%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 02-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Liquidity: current ratio 28.41, cash €1.2m
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Equity €1.5m (96.3% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Size: total assets €1.6m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 16-07-2026, 15 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
15 d early
2024
29 d early
2023
20 d early
2022
33 d early
2021
13 d early
2020
19 d early
2019
17 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 21 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 12 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
02-10-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2025 · abbreviated…
  2. Annual accounts filedfiscal year 2024 · abbreviated…
  3. Highest result since 2018net €345,014 ▲14.4%

Key points

  • Positive: Among the best 7% on solvencysector median 59.8% · 2,603 companies 96.3% View
  • Caution: Result fell in 2025from €345,014 to €181,088 ▼ 47.5% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €181,088 8 years View

By topic

Financials

Fiscal year
2025
Total assets
€1.6m
Profit
€181,088
Solvency
96.3%
Total assets▼ 2.9%
Net result
20182025
Go to Financials

Timeline

Events
14
Since
2017
Next accounts
by 31-07-2027
  1. 16-07-2026Annual accounts filed
  2. 02-07-2025Annual accounts filed
  3. 31-12-2024Highest result since 2018
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
17-12-2010
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.